MRP ₹63.5
(Inclusive of all Taxes)
₹9.5 Cashback (15%)
Secure Payment
India's Most Trusted Pharmacy
Genuine Products
निर्माता/विपणक :
सेवन का प्रकार :
वापसी नीति :
इसके बाद या इस पर समाप्त होता है :
Have a query?
Drug-Drug Interactions
Drug-Drug Interactions
Login/Sign Up
Co-administration of Ketorolac and Cvroz ASP-75 Capsule may increase the risk of side effects.
How to manage the interaction:
Taking Ketorolac with Cvroz ASP-75 Capsule is not recommended but can be taken together if prescribed by a doctor. However, consult a doctor if you experience unusual bleeding or bruising, dizziness, tarry stools, coughing up or vomiting fresh or dried blood, severe headache and weakness. Do not stop using any medications without talking to a doctor.
Combining Ketorolac tromethamine with Cvroz ASP-75 Capsule can increase the risk of adverse effects.
How to manage the interaction:
Taking Cvroz ASP-75 Capsule with Ketorolac tromethamine is not recommended, as it results in an interaction, it can be taken if advised by a doctor. Do not stop using any medications without a doctor’s advice.
Co-administration of Cvroz ASP-75 Capsule with lenalidomide may increase the risk of a rare condition called rhabdomyolysis (breakdown of skeletal muscle tissue).
How to manage the interaction:
Although there is an interaction between lenalidomide and Cvroz ASP-75 Capsule, it can be taken if prescribed by a doctor. However, if you experience muscle pain, tenderness, or weakness, consult the doctor immediately. Do not discontinue any medications without consulting a doctor.
Co-administration of Saquinavir and Cvroz ASP-75 Capsule can increase the blood levels of Cvroz ASP-75 Capsule and can increase the risk of developing liver damage and rhabdomyolysis(breakdown of skeletal muscle tissue).
How to manage the interaction:
Co-administration of Saquinavir and Cvroz ASP-75 Capsule can lead to an interaction, it can be taken if advised by your doctor. However, if you experience any symptoms like muscle pain, tenderness, weakness, dark-colored urine, fever, chills, joint pain or swelling, unusual bleeding or bruising, skin rash, itching, loss of appetite, fatigue, nausea, vomiting, and yellowing of the skin or eyes, consult the doctor immediately. Do not stop using any medications without a doctor's advice.
Co-administration of Cvroz ASP-75 Capsule and Atazanavir can increase the blood levels of Cvroz ASP-75 Capsule and can increase the risk of liver damage and rhabdomyolysis( breakdown of skeletal muscle tissue).
How to manage the interaction:
Co-administration of Cvroz ASP-75 Capsule and Atazanavir can lead to an interaction, it can be taken if advised by your doctor. However, if you experience any symptoms like muscle pain, tenderness, weakness, dark-colored urine, fever, chills, joint pain or swelling, unusual bleeding or bruising, skin rash, itching, loss of appetite, fatigue, nausea, vomiting, and yellowing of the skin or eyes, consult the doctor immediately. Do not stop using any medications without a doctor's advice.
Co-administration of Ritonavir and Cvroz ASP-75 Capsule can increase the blood levels of Cvroz ASP-75 Capsule.
How to manage the interaction:
Co-administration of Ritonavir and Cvroz ASP-75 Capsule can lead to an interaction, it can be taken if advised by your doctor. However, if you experience any symptoms like muscle pain, tenderness, weakness, dark-colored urine, fever, chills, joint pain or swelling, unusual bleeding or bruising, skin rash, itching, loss of hunger, weakness, nausea, vomiting, and yellowing of the skin or eyes, consult the doctor immediately. Do not stop using any medications without a doctor's advice.
Coadministration of Nicotinamide with Cvroz ASP-75 Capsule may increase the risk and severity of side effects like rhabdomyolysis (breakdown of skeletal muscle) or kidney damage which can be fatal.
How to manage the interaction:
Taking Nicotinamide with Cvroz ASP-75 Capsule together can result in an interaction, but it can be taken if your doctor has advised it. If you notice any symptoms like unexplained muscle pain, muscle stiffness or tenderness, fever, dark-coloured urine, or weakness, you should contact your doctor immediately. Do not stop using any medications without first talking to your doctor.
Co-administration of Cvroz ASP-75 Capsule and Fenofibrate can increase the blood levels of Cvroz ASP-75 Capsule and can increase the risk of liver damage and rhabdomyolysis(breakdown of skeletal muscle tissue).
How to manage the interaction:
Co-administration of Cvroz ASP-75 Capsule and Fenofibrate can lead to an interaction, it can be taken if advised by a doctor. However, if you experience any symptoms like muscle pain, tenderness, weakness, dark-colored urine, fever, chills, joint pain or swelling, unusual bleeding or bruising, skin rash, itching, loss of appetite, fatigue, nausea, vomiting, and yellowing of the skin or eyes, consult the doctor immediately. Do not stop using any medications without a doctor's advice.
Co-administration of Gemfibrozil and Cvroz ASP-75 Capsule may increase the risk or severity of side effects like muscle injury.
How to manage the interaction:
Co-administration of Gemfibrozil and Cvroz ASP-75 Capsule can lead to an interaction, it can be taken if advised by a doctor. However, if you experience any symptoms like muscle pain, tenderness, weakness, or dark-colored urine, consult the doctor immediately. Do not stop using any medications without a doctor's advice.
Co-administration of leflunomide and Cvroz ASP-75 Capsule can increase the risk of developing liver problems.
How to manage the interaction:
Co-administration of Leflunomide and Cvroz ASP-75 Capsule can lead to an interaction, they can be taken together if prescribed by a doctor. However, if you experience fever, chills, joint pain or swelling, unusual bleeding or bruising, skin rash, itching, less desire to eat, fatigue, nausea, vomiting, abdominal pain, or yellowing of the skin or eyes, contact a doctor immediately. Do not discontinue any medications without consulting a doctor.
Drug-Food Interactions
Drug-Food Interactions
Login/Sign Up
All Substitutes & Brand Comparisons
RX
Rosycap-ASP 10 mg/75 mg Capsule 15's
Akumentis Healthcare Ltd
₹103.5
(₹6.21 per unit)
8% COSTLIERRX
Turbovas ASP Capsule 15's
Micro Labs Ltd
₹105
(₹6.31 per unit)
10% COSTLIERRX
Statpure A 10 mg/75 mg Capsule 15's
Mankind Pharma Pvt Ltd
₹124.5
(₹7.47 per unit)
30% COSTLIER
शराब
असुरक्षित
शराब का सेवन असुरक्षित है क्योंकि यह चक्कर आना जैसे दुष्प्रभावों को बदतर बना सकता है और रक्तचाप को बढ़ा सकता है।
गर्भावस्था
असुरक्षित
गर्भावस्था के दौरान Cvroz ASP-75 Capsule 10's का उपयोग असुरक्षित है क्योंकि इसका भ्रूण पर हानिकारक प्रभाव पड़ता है। यदि रोगी Cvroz ASP-75 Capsule 10's का उपयोग करते समय गर्भवती हो जाती है, तो कृपया तुरंत बंद कर दें, और आपको भ्रूण के लिए संभावित जोखिमों के बारे में पता होना चाहिए। कृपया अपने चिकित्सक से परामर्श करें यदि आप गर्भधारण करने की योजना बना रही हैं या Cvroz ASP-75 Capsule 10's शुरू करने से पहले ही गर्भवती हैं।
स्तनपान
असुरक्षित
यदि आप एक स्तनपान कराने वाली माँ हैं तो Cvroz ASP-75 Capsule 10's के उपयोग की अनुशंसा नहीं की जाती है क्योंकि यह स्तनपान करने वाले शिशु को प्रभावित कर सकता है। Cvroz ASP-75 Capsule 10's शुरू करने से पहले कृपया अपने चिकित्सक से परामर्श करें।
ड्राइविंग
सावधानी
यदि आप Cvroz ASP-75 Capsule 10's का उपयोग करते समय चक्कर या उनींदापन का अनुभव करते हैं तो वाहन न चलाएं या मशीनरी न चलाएं। Cvroz ASP-75 Capsule 10's कभी-कभी धुंधली दृष्टि भी पैदा कर सकता है, इसलिए ऐसी स्थितियों में गाड़ी चलाने से बचें। अगर लक्षण लंबे समय तक बने रहते हैं तो चिकित्सा सहायता लें।
जिगर
सावधानी
यदि आपको जिगर की बीमारियों या यकृत हानि का कोई इतिहास है तो अपने डॉक्टर को बताएं। Cvroz ASP-75 Capsule 10's लिखने से पहले आपका डॉक्टर लाभ और संभावित जोखिमों का आकलन करेगा।
गुर्दा
सावधानी
यदि आपको गुर्दे की बीमारियों का कोई इतिहास है तो अपने डॉक्टर को बताएं। Cvroz ASP-75 Capsule 10's लिखने से पहले आपका डॉक्टर लाभ और संभावित जोखिमों का आकलन करेगा।
बच्चे
असुरक्षित
16 साल से कम उम्र के बच्चों के लिए Cvroz ASP-75 Capsule 10's की सिफारिश नहीं की जाती है। दुनिया भर में सक्षम अधिकारियों द्वारा बच्चों पर इस दवा के सीमित परीक्षण के कारण बच्चों में Cvroz ASP-75 Capsule 10's की सुरक्षा और प्रभावकारिता स्थापित नहीं की गई है।
Disclaimer
Author Details
